Organoids – high hopes and bioethical dilemmas
From an ethical perspective, this new technology raises a whole range of issues. These include important caveats in relation to the use of human embryonic stem cells or the application of gene therapies to prevent or treat diseases. Jürgen Knoblich believes that “the development of organoids is unexplored scientific territory. As a researcher, I am fascinated by the huge potential of this technology. However, I also believe it’s my job to actively promote dialogue around responsible research and to engage the wider public in the discussion”. In 2013, the stem cell specialist made scientific headlines worldwide with his laboratory-cultivated brain models. In the latest policy statement issued in collaboration with the immunologist and geneticist Hans Clevers and the bioethicist and Member of the Dutch Parliament, Annelien Bredenoord, the researchers also examined for the first time the most important ethical dimensions of organoid research. According to Knoblich, “we hope that our work has created a solid foundation for the establishment of framework conditions for responsible engagement with this new technology”.